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ABSTRACT
Objective: Oxidative stress contributes to the pathophysiology of exposure to environmental pollutants and to different free radical generating 
biochemical reactions in a human system leading to various types of age-related ailments. An antioxidant is a substance capable of preventing 
or slowing down oxidation of other molecules. Administration of different natural or synthetic antioxidants can ably lead to prevention and 
attenuation of such stress-induced biochemical alterations. Best examples of natural antioxidants are plant-derived flavonoids. The present 
study has been designated to determine antioxidant properties in antidepressant compound doxepin which is structurally similar to flavonoid 
quercetin.
Methods: Antioxidant capacity in doxepin was determined with help of several standard conventional procedures such as phosphomolybdenum 
assay, Ferric ion and cupric ion reducing power assays, ferrous ion chelating activity assay, hydrogen peroxide, and nitric oxide scavenging activity 
assays.
Results: Doxepin showed a stable rise in its antioxidant activity in a dose-dependent manner as determined by ferric as well as cupric ion reducing 
capacity and by phosphomolybdenum assay. An almost identical observation was noted while determining ferrous ion chelating activity. Furthermore, 
doxepin showed a strong nitric oxide scavenging activity in all the concentrations used in the study while its hydrogen peroxide scavenging activity 
was only observed at 500 µg/ml of doxepin.
Conclusion: Thus, our study opens up a new vista in search for antioxidants not only from plant sources but also from clinically established 
pharmaceutical compounds that are already in practical use among patients.
Keywords: Antioxidant, Antidepressant, Doxepin, Quercetin, Flavanol, Flavonoids.
INTRODUCTION
The driving forces to sustain life are some of the processes of 
biochemical reactions which continue till death of human beings. Such 
incessant processes in our bodies generate several bio-molecules, of 
which some are reactive oxygen species (ROSs) and free radicals [1]. 
Occupational exposure to environmental pollutants such as pesticides, 
toxic chemical wastes, direct as well as indirect cigarette smoke, 
gasoline exhaust, urban air pollutants ozone and radiation, and physical 
stress have been demonstrated to produce similar reactive molecular 
species in our bodies [2]. These molecules cause oxidative degradation 
of lipids, proteins, and DNA, activation of procarcinogens, inhibition 
of cellular and antioxidant defense system, depletion of sulfhydryls, 
altered calcium homeostasis, changes in gene expression, and induction 
of abnormal proteins and contribute significantly to human disease 
pathophysiology [3-5]. Certain substances known as antioxidants act as 
preventive oxidants caused by such free radicals and ROS. Halliwell [6] 
defined antioxidants as “any substance that delays, prevents or removes 
oxidative damage to a target molecule.” The antioxidant vitamins such 
as vitamins C and E, ß-carotene and proanthocyanidins, antioxidant 
minerals such as zinc and selenium, and antioxidant enzymes such 
as glutathione, superoxide dismutase, and catalase, have been vividly 
studied for their potential role in the prevention of degenerative 
diseases including tumor growth and carcinogenesis [5-8]. Research 
evidence has suggested a link between increased levels of ROS and 
disturbed activities of enzymatic and nonenzymatic antioxidants in 
diseases associated with aging [9].
Through several studies, the different modes of action of various 
antioxidants have been observed: As preventers of oxidation reactions 
caused by free radicals, free lipid radical formation inhibitors, by 
breaking the chain of auto-oxidation reactions, as quenchers of singlet 
oxygen, by converting the hydroperoxides through reduction and the 
metal pro-oxidants by chelating metals into stable compounds, and 
finally as inhibitors of pro-oxidative enzymes [10-14].
Flavonoids are a class of naturally occurring polyphenolic compounds, 
isolated from a wide range of vascular plants. They generally occur in 
plants as glycosylated derivatives, and they contribute to the brilliant 
shades of blue, scarlet, and orange, in leaves, flowers, and fruits. Apart 
from various vegetables and fruits, flavonoids are found in seeds, nuts, 
grains, spices, and different medicinal plants as well in beverages, such 
as wine particularly red wine, tea, and at lower levels in beer [15]. 
The basic flavonoid structure is the flavan nucleus, which consists of 
15 carbon atoms arranged in three rings. Different biological activities 
of flavonoids had been the subject of several studies in the past years, 
and it has been revealed that they exhibit antimicrobial, antiallergenic, 
antiviral, anti-inflammatory, and vasodilating actions. However, most 
interests have been devoted to the antioxidant activity of flavonoids, 
which is due to their ability to reduce free radical formation and to 
scavenge free radicals [16].
Among the flavonol subclass of flavonoids, quercetin is a major 
representative. Quercetin is the flavonoid widely distributed in nature 
and is one of the most abundant dietary flavonoids with an average 
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daily consumption of 25-50 mg. Quercetin has been observed to act 
mainly in the prevention of oxidation of low-density lipoproteins by 
scavenging free radicals and chelating transition metal ions [17].
A large number of studies by different workers from several parts of the 
world have repeatedly provided enough evidence that pharmaceutical 
compounds synthesized for a particular pharmacological action often 
simultaneously possess some other function equally efficiently [18-21].
Such observations have repetitively proved that multiplicity of function 
in chemically synthesized drugs is a rule rather than an exception. With 
this background, the structural similarity of the synthetic antidepressant 
compound doxepin with the known antioxidant quercetin has 
replenished sufficient evidence to explore antioxidant action in this 
drug. Moreover, there is hardly any synthetic antidepressant available 
in the market for human consumption except the vitamins. The present 
study was therefore designed to carry out an elaborate experimental 
work to prove the efficacy of doxepin as an antioxidant with the help of 
a number of known standard tests.
METHODS
Drug
Doxepin was obtained as pure dry powder from Sigma-Aldrich, USA. It 
was preserved at 4°C. The drug powder was soluble in water.
Chemicals and reagents
All the chemicals and reagents used in the following different assays 
were purchased from Loba Chemie (Mumbai, India), Sisco Research 
Laboratory (SRL, Mumbai, India), Merck (Bengaluru, India), and from 
HiMedia (Mumbai, India). They were all of analytical grade.
Preparation of the sample
For every analysis, a freshly prepared working solution of 1 mg/ml of 
the drug powder was prepared by dissolving in Milli-Q grade water.
Protocols for detection of in vitro antioxidant and free radical 
scavenging activity
Total antioxidant capacity determination
The phosphomolybdenum method as described by Prieto et al. [22] was 
followed for the estimation of total antioxidant capacity. This assay is 
based on the principle of reduction of Mo (VI) to Mo (V) by an agent and 
subsequent formation of a green phosphate/Mo (V) complex at acidic pH. 
Tubes containing 0.2 ml aliquots of concentrations 25, 50, 100, 200, and 
500 µg/ml of the drug solution were mixed with 1.8 ml of distilled water 
and 2 ml of phosphomolybdenum reagent (0.31 M sulfuric acid, 2 mM 
sodium phosphate, and 4 mM ammonium molybdate). The amount of 
0.2 ml of water was used instead of doxepin as the control. All of the tubes 
were then incubated in a water bath set at 95°C for 90 minutes. After 
cooling to room temperature, absorbances were measured at 695 nm 
using a ultraviolet-visible (UV-VIS) spectrophotometer (Evolution 201, 
Thermo Scientific) against the blank. A standard curve was prepared 
using different concentrations of ascorbic acid (1000, 500, 250, 
125, 62.5, and 31.25 µg/ml). The total antioxidant activity is expressed 
as the µg/ml equivalents of ascorbic acid, defined as ascorbic acid 
equivalent activity and calculated as % of inhibition=(Ao−A1)/Ao×100, 
where Ao is the absorbance of the control (blank, without drug) and A1 is 
the absorbance of the different drug solutions.
Ferric ion reducing capacity determination
This assay was performed by following the method as described by Prieto 
et al. [22]. Accordingly, 0.1 ml aliquots of different concentration of the 
sample solution (25 µg/ml, 50 µg/ml, 100 µg/ml, 200 µg/ml, 500 µg/ml) 
were taken in different tubes and to each one of them 0.5 ml of deionized 
water and 0.09 ml of 95% ethanol were added. Subsequently, further 
addition of each of 0.15 ml each of 1 M HCl, 1% potassium ferrocyanide, 
0.05 ml of 1% sodium dodecyl sulfate, and 0.1 ml of 0.2% ferric chloride 
were followed. The tubes were then vortexed properly, and readings 
were taken at 700 nm in a spectrophotometer (Evolution 201, Thermo 
Fisher) against the blank. Potent antioxidants reduce Fe3+ ions to Fe2+ 
which forms a Prussian blue colored complex with the ferrocyanide. The 
intensity of the Prussian blue color in the reaction tubes as measured 
at the said wavelength monitors the amount of the Fe2+ ions generated. 
Thus, a higher ferric ion reducing power was indicated by a greater 
absorbance. A standard curve was prepared by different concentrations 
of ascorbic acid (1000, 500, 250, 125, 62.5 and 31.25 µg/ml).
Cupric ion reducing capacity determination
For this assay, the protocol as described by Apak et al. [23] was 
followed. The basic principle is based on the measurement of 
absorbance at 450 nm by the formation of stable colored complex 
between neocuproine and copper (I). Copper (II)-neocuproine 
(Cu [II]-Nc) reagent is utilized as the oxidizing agent for the reaction. 
As for the purpose, 0.6 ml volume each of double distilled water, 
cupric chloride (0.01 M), and sodium citrate (25% w/v) were added to 
correctly labeled tubes and shaked vigorously for proper mixing. This 
was followed by the addition of 0.6 ml volume of sample solution in 
increasing concentrations (25, 50, 100, 200, and 500 µg/ml) to each of 
the respective tubes. Finally, 0.6 ml neocuproine (0.0075 M) was added 
to all of them and then the reaction mixtures were incubated at room 
temperature for 30 minutes. Absorbances were taken at 450 nm using 
a UV-VIS spectrophotometer (Evolution 201, Thermo Scientific) against 
the blank. A standard curve was prepared by different concentrations of 
ascorbic acid (1000, 500, 250, 125, 62.5, and 31.25 µg/ml). The results 
are expressed as µg/ml equivalents of ascorbic acid.
Ferrous ion chelating activity determination
The standard method as described by [24] was followed for the 
estimation of ferrous ion chelating ability of the drug doxepin. The basic 
principle of this assay is that ferrozine, which initiates the reaction by 
combining with divalent iron to form a stable magenta complex species, 
the absorbance of which is measured at 562 nm. In the presence of 
potent metal ion chelators, the ferrozine-Fe2+ complex formation is 
interrupted as they compete with ferrozine in chelating the ferrous 
ions. Briefly, to 3 ml of different concentrations of the drug solution 
(25, 50, 100, 200, 500 µg/ml), 0.15 ml of 2 mM FeCl2 was added. The 
reaction was then initiated by the addition of 0.3 ml of 5 mM ferrozine 
into the mixture and incubated at room temperature for 10 minutes. 
Finally, the absorbance of the ferrozine-ferrous ion complex was read 
at 562 nm against the blank. Ethylene diamino tetra acetate was used 
as the positive control for this assay. The chelating activity of the drug 
was calculated as ferrous ion chelating ability in %=(1-[test sample 
absorbance/blank sample absorbance])×100%.
Hydrogen peroxide scavenging activity determination
Although hydrogen peroxide is not a free radical, in physiological 
system, it forms complexes with metals such as iron and copper and 
reacts to produce highly reactive hydroxyl radicals which are extremely 
toxic to the living tissues [25]. According to the modified method of 
determining hydrogen peroxide scavenging activity by Mukhopadhyay 
et al. [26], 1.5 ml of different concentrations of the drug solution 
(25, 50, 100, 200, 500 µg/ml) were added to 0.25 ml of 1 mM ferrous 
ammonium sulfate and mixed and then to each tube, 62.5 µL of 5 mM 
hydrogen peroxide were added, and all of them were then incubated 
for 5 minutes at room temperature in dark. Following the incubation, 
1.5 ml volume of 1,10-phenanthroline monohydrate was pipetted into 
the reaction mixtures and again kept for 1 minute in dark at room 
temperature. After that, absorbances were measured at 510 nm using 
a UV-VIS spectrophotometer (Evolution 201, Thermo Scientific) against 
the blank. Ascorbic acid was used as the reference standard of the assay. 
The percentage of hydrogen peroxide scavenging activity of the drug 
was calculated as given below:
% of scavenging activity=(Atest−Ablank)×100.
Where Ablank is the absorbance of solution containing only ferrous 
ammonium sulfate and 1,10-phenanthroline and Atest is the absorbance 
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of the solution containing ferrous ammonium sulfate, hydrogen 
peroxide, 1,10-phenanthroline and along with test compound having 
expected hydrogen peroxide scavenging activity.
Nitric oxide scavenging activity determination
Chronic physiological generation of nitric oxide leads to a number of 
significant toxic effects including vascular collapse with septic shock, 
and it also plays a key role in inflammatory conditions such as juvenile 
diabetes, multiple sclerosis, arthritis, and ulcerative colitis [27]. For the 
assay to estimate the nitric oxide scavenging activity of antioxidants, the 
method as described by Chaudhuri et al. [28] was followed. Here, sodium 
nitroprusside is used as the nitric oxide donor, which when generated in 
the system interacts with oxygen to form the highly reactive peroxynitrite 
anion (ONOO−), and this can be measured by Griess-Illosvoy reaction [29]. 
As per the protocol, 1 ml of different concentrations of doxepin (25, 50, 
100, 200, and 500 µg/ml) was added in tubes to which 1 ml of 10 mM 
sodium nitroprusside was given and mixed properly. This was followed 
by incubation for 3 hrs at room temperature. After this, 1 ml of Griess 
reagent A (1% w/v sulfanilamide) was pipetted into each of the tubes, 
and again they were incubated for 20 minutes at 30°C. Finally, the assay 
is completed with the addition of 1 ml of Griess reagent B (0.1% w/v 
naphthylethylenediamine dihydrochloride or NED) to the mixture 
tubes and again incubated for 10 minutes in dark at room temperature. 
Absorbances were recorded at 546 nm using a UV-VIS spectrophotometer 
(Evolution 201, Thermo Scientific) against the blank. Ascorbic acid 
was used as the positive control. The percentage of nitric oxide radical 
scavenging activity of the drug solutions was calculated as given below:
% of scavenging activity=(absorbance of control−Absorbance of 
test/Absorbance of control)×100.
Statistical analyses
Statistical analysis was done using One way Anova following Bonferoni 
post hoc test (GraphPad Prism version 5.0 software).
RESULTS
Determination of total antioxidant activity by phosphomolybdenum 
assay
Our result indicates in an increasing trend of total antioxidant activity 
with increase in concentration of the antidepressant compound ranging 
from 25 µg/ml to 500 µg/ml. The obtained average angular error (AAE) 
values have been depicted in the graph (Fig. 1) against the different 
concentrations of doxepin. From the bar diagram, it can be observed 
that doxepin has a moderately high molybdenum ion reducing ability 
with the values ranging from 25.3±1.47 AAE at 25 µg/ml and reaching 
its maximum to 174.35±8.39 AAE at 500 µg/ml.
Detection of ferric ion reducing activity in doxepin
Researchers worldwide have studied that compounds which have 
potent reducing power can act as electron donors and also can reduce 
the oxidized intermediates. This is a measure of significant antioxidant 
potentiality of a compound [30,31]. Observations from this experiment 
indicate that there is a positive increase in the ferric ion reducing ability 
of doxepin with its increasing concentration (Fig. 2). The ascorbic acid 
equivalent values ranged from 7.69±3.77 AAE at 25 µg/ml and reaching 
its maximum to 22.86±5.66 AAE at 500 µg/ml of the drug.
Evaluation of cupric ion reducing activity
Molecules having antioxidant capacities, specially belonging to the 
class of hydroxyl radicals of phenolic compounds, have the ability 
to reduce Cu2+ ions to Cu+. These Cu+ ions generated in the system, 
then react and form the colored complex with neocuproine whose 
absorbance is measured at the said wavelength [23]. Doxepin exhibited 
increased reduction of Cu2+ ion to Cu+ with increasing concentrations 
of the drug. However, its cupric ion reducing ability is much lower in 
comparison with other scavenging or reducing abilities, as shown 
by the observations, ranging from 2.54±0.75 AAE at 25 µg/ml, and 
reaching its maximum to 6.5±1.11 AAE at 500 µg/ml.
Action of doxepin on ferrous ion chelating property
The chelating activity of the drug was estimated on the basis of the 
measurement of color reduction of the ferrozine - Fe2+ complex. As 
transition metal ions such as Fe2+ can move single electrons which 
result in the formation and propagation of many radical reactions, the 
ability to chelate them is considered to be a significant measurement 
of a compound’s antioxidant capacity [32]. Our study shows that 
doxepin was able to potentially chelate the metal ion which increased 
in a dose-dependent manner. The percentage of scavenging activity 
was calculated and plotted against the different concentrations of the 
drug (Fig. 3). The values of the activity percentage varied between 
4.88±1.05% at 25 µg/ml and 35.53±1.55% at 500 µg/ml.
Fig. 1: The total antioxidant activity of doxepin by the 
phosphomolybdenum assay where the X-axis denotes the 
different concentration of the drug (µg/ml). *@ means 
p<0.01, compared to Doxepin (25) and Doxepin (50). The 
assay was repeated three times (n=3). Values are expressed as 
mean±standard deviation
Fig. 2: The ferric ion reducing activity of doxepin by the ferric 
reducing antioxidant power assay where the X-axis denotes the 
different concentration of the drug (µg/ml).  *@ means p<0.01, 
compared to Doxepin (25). The assay was repeated three times 
(n=3). Values are expressed as mean±standard deviation
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Effect of doxepin on hydrogen peroxide scavenging property
As mentioned earlier, hydrogen peroxide although a weak oxidizing agent, 
but it can further generate toxic hydroxyl radical in living systems. Following 
the protocol as described by Mukhopadhy et al. [26], the percentage of 
hydrogen peroxide scavenging activity of doxepin was calculated and it was 
plotted against the different concentrations of the drug (Fig. 4). As from the 
figure, it can be observed that in all the concentrations used in the study, 
doxepin showed 20-30% of hydrogen peroxide scavenging activity.
Determination of nitric oxide scavenging activity of doxepin
Studies from several researches have revealed that nitric oxide is 
an important free radical which has a key role in generating toxic 
inflammatory processes in the physiological system. Our experiment 
proves that doxepin significantly inhibits nitrite formation by directly 
competing with oxygen to react with nitric oxide. As observed from 
Fig. 5, in all the concentrations, doxepin showed high levels of nitric 
oxide scavenging activity ranging from 50% to 70%.
DISCUSSION
Recent scientific investigations throughout the world suggest that 
there is strong evidence of involvement of oxidative stress in the 
pathogenesis of cancer, atherosclerosis, inflammatory diseases, and 
neurodegenerative disorders such as Alzheimer, parkinsonism, and 
convalescent. Such an oxidative stress is primarily induced by the RO 
which include both oxygen radical and nitric oxide radicals. However, 
certain non-radical derivatives of oxygen like hydrogen peroxide, 
hypochlorous acid, and singlet oxygen can also be involved in this 
process [33]. These free radicals synthesized by various biochemical 
reactions in the human body can cause structural and functional 
damage to the neurons, proteins, lipids, nucleic acids, and different 
cellular molecules [34]. Thus, there is an urgent need for the search 
of free radical scavengers or antioxidants for the prevention of such 
cellular damages [35]. Although most of the studies are focused 
either on synthesized new molecules in pharmaceutical industries or 
detection of antioxidants in plant products, this study has been directed 
to search for antioxidants among known pharmacological compounds 
with structural similarity with flavonoids of plant origin which possess 
Fig. 3: Graphical representation showing the ferrous ion 
chelating activity of doxepin where the X-axis denotes different 
concentrations of doxepin (µg/ml). *# means  p<0.001, compared 
to rest of the concentrations; @ means p<0.01, compared to rest 
of the concentrations; * means p<0.05, compared to rest of the 
concentrations.  The assay was repeated three times (n=3). Values 
are expressed as mean±standard deviation
Fig. 4: Graphical representation showing the hydrogen peroxide 
scavenging activity of doxepin where the X-axis denotes different 
concentrations of doxepin (µg/ml).  *@ means p<0.01, compared 
to rest of the concentrations. The assay was repeated three times 
(n=3). Values are expressed as mean±standard deviation
Fig. 5: Graphical representation showing the nitric oxide 
scavenging activity of doxepin where the X-axis denotes different 
concentrations of doxepin (µg/ml).  The assay was repeated three 
times (n=3). Values are expressed as mean±standard deviation
Fig. 6: The cupric ion reducing activity of doxepin by the cupric 
reducing antioxidant capacity assay where the X-axis denotes the 
different concentration of the drug (µg/ml).  *# means p<0.001, 
compared to Doxepin (25); @ means p<0.01, compared to rest 
Doxepin (200) and Doxepin (500); * Means p<0.05, compared to 
Doxepin (25). The assay was repeated three times (n=3). Values 
are expressed as mean±standard deviation
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potent antioxidant properties [36,37]. The antidepressant drug 
doxepin was found to resemble structurally the plant-derived flavonoid 
compound quercetin.
While determining the total antioxidant activity in doxepin by 
phosphomolybdenum assay, it was found that there was a steady, 
gradual rise in the activity with the increase in the amount of the 
compound with respect to amino acid equivalent (Fig. 1). Again in the 
ferric reducing antioxidant power assay, doxepin distinctly revealed 
a stepwise increase in antioxidant property much like the control 
(Fig. 2). Subsequently by the cupric reducing antioxidant capacity assay 
process, doxepin showed gradually increasing reduction of Cu++ ion to 
Cu+ with elevation in the amount of doxepin (Fig. 6). In a separate study, 
doxepin showed definite Fe2+ chelating action whose values increased 
in a gradual manner from 25 to 200 µg/ml concentration, however, 
with 500 µg/ml of the drug, there was a very sharp rise in the values 
(Fig. 3). Doxepin although had shown hydrogen peroxide scavenging 
function, the values hardly varied between the amounts of 25 and 
200 µg/ml, a distinct rise in action was observed with 500 µg/ml of the 
drug (Fig. 4). Finally, doxepin revealed nitric oxide scavenging property, 
the percentage activity was >50 at 25 µg/ml of doxepin and remained 
almost the same up to 100 µg/ml of the drug. However, the values were 
slightly higher with 200 µg/ml of doxepin but sharply higher with 
500 µg/ml of the compound.
Free radicals are known to cause oxidation of biomolecules in the 
human system, and antioxidant-rich diets can protect the body from 
free radicals [38]. Synthetic antioxidants such as butylhydroxyanisole 
or butylhydroxytoluene have been used to decelerate such processes. 
However, due to their unstable and volatile nature, scarcity of 
information regarding their safety, stability, and carcinogenicity 
these chemical compounds are still not in use in health-care systems 
[38,39]. Non-enzymatic antioxidants and antioxidant enzymes 
counteract the effects of ROS and RNS leading to the risk of oxidative 
stress [40].
The non-enzymatic antioxidants include the vitamins of which 
vitamin C and vitamin E are most promising agents and are in regular 
use. Epidemiological studies have shown that diets containing 
these vitamins help reduce risks of cardiovascular disease, stroke, 
and even cancer [41,42]. Both of these vitamins along with several 
other antioxidant vitamins are available in the market for human 
consumption, but there is practically no synthetic compound that can 
act as antioxidants. There are only a few reports on the detection of 
antioxidants property in synthesized chemical compounds. In 2005, 
Green and Ashwood reported on free radical scavenging activity 
of several synthetic compounds for neuroprotection in stroke in 
experimental animals [43]. However, preclinical studies with such 
compounds were neither comprehensive nor consistent. One of 
these compounds, tirilazad was investigated by some researchers but 
human trials demonstrated no effect on mortality or other outcomes in 
several disorders [44]. Thus, in view of inadequacy of information on 
possibilities of developing or obtaining synthesized antioxidants other 
than the vitamins doxepin was selected to determine its antioxidant 
potentiality on the basis of its structural similarity with quercetin, the 
known highly active antioxidant.
Doxepin is a pharmaceutical compound which is primarily given 
to patients suffering from acute mental depression and anxiety 
disorders. Doxepin is sometimes prescribed for patients complaining 
about insomnia as well. However, it has also been found to treat 
chronic idiopathy as the second line of treatment. Most of the above 
disorders are found to occur among elderly people, and doxepin 
is administered on a regular basis for long periods. Therefore, 
the patients who are on a regular intake of doxepin are likely to 
be benefitted to have an antioxidant simultaneously. A recent 
study has proved the efficacy of the antidepressant antipsychotic 
agent imipramine to process antioxidant properties also [45]. 
Therefore, the concept of the presence of multiplicity of action 
among pharmacological compounds is being proved again. Much 
like imipramine, toxicity profile and human tolerance levels of 
doxepin are well documented. Therefore, both these two drugs can 
be developed further by structural modifications to produce highly 
active antioxidants that can be safely administered to patients of all 
ages and also those who have greater chances of acquiring cancer, 
atherosclerosis, neurodegenerative diseases, and many other serious 
disorders. Therefore, such investigations are likely to open up new 
avenues of research on detection and determination of possible 
antioxidants among known pharmaceutical compounds.
CONCLUSION
Human body possesses a complex system of natural enzymatic and 
non-enzymatic antioxidant defense mechanisms that can counteract 
moderate to highly toxic effects of free radicals and other oxidants 
that are responsible for many human diseases including cancer. In 
view of the necessity to discover new active antioxidants, a search was 
directed to find out such agents from already known pharmacological 
compounds. On the basis of information of the presence of powerful 
antioxidant function in naturally occurring flavonoids in plants, the 
structurally similar compound doxepin was selected, and intensive 
studies have confirmed doxepin to be a highly potent antioxidant. In 
this way, novel antioxidants can be discovered from already known 
pharmaceutical compounds that possess structural similarity with 
known antioxidants including flavonoids.
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